Literature DB >> 11124935

Regulation of the human MAT2A gene encoding the catalytic alpha 2 subunit of methionine adenosyltransferase, MAT II: gene organization, promoter characterization, and identification of a site in the proximal promoter that is essential for its activity.

A B Halim1, L LeGros, M E Chamberlin, A Geller, M Kotb.   

Abstract

Mammalian methionine adenosyltransferase II (MAT II) consists of a catalytic alpha2/alpha2' and a regulatory beta subunit. Up-regulation of alpha2 subunit expression is associated with increased intracellular levels of S-adenosylmethionine, the major methyl group donor and a key compound in cell metabolism and polyamine synthesis. Previous studies have shown that expression of the alpha2 subunit is differentially regulated in normal and malignant cells. To delineate the molecular basis for the differential regulation of alpha2 subunit expression, we cloned and characterized the human MAT2A gene and its promoter and defined regions that contain enhancer and repressor elements. Detailed functional characterization of the proximal promoter of the MAT2A gene revealed the formation of three major protein-DNA complexes with probes containing three Sp1 sites (Sp1-1 at -14, Sp1-2 at -47, and Sp1-3 at -69). Competition with a probe copying sequence between -76 and -54, which contains the Sp1-3 site only, or mutation of this site, abolished complex formation. Furthermore, mutation of the Sp1-3 site, but not the Sp1-1 or Sp1-2 sites, inhibited the in vivo promoter activity by approximately 85%. Supershift assays showed that the transcription factors Sp2 and Sp3 are part of the complexes formed at the Sp1-3 site, and that Sp1 does not appear to be directly involved. The data indicate that complex formation is initiated at site Sp1-3, which appears to be essential for promoter activity. However, other regions of the proximal promoter may also contribute to the regulation of MAT2A gene expression. These studies may lead to the delineation of the molecular basis for the differential regulation of MAT2A expression in normal and leukemic T cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11124935     DOI: 10.1074/jbc.M002347200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  An endogenously anti-inflammatory role for methylation in mucosal inflammation identified through metabolite profiling.

Authors:  Douglas J Kominsky; Simon Keely; Christopher F MacManus; Louise E Glover; Melanie Scully; Colm B Collins; Brittelle E Bowers; Eric L Campbell; Sean P Colgan
Journal:  J Immunol       Date:  2011-04-22       Impact factor: 5.422

2.  MAT2A mutations predispose individuals to thoracic aortic aneurysms.

Authors:  Dong-chuan Guo; Limin Gong; Ellen S Regalado; Regie L Santos-Cortez; Ren Zhao; Bo Cai; Sudha Veeraraghavan; Siddharth K Prakash; Ralph J Johnson; Ann Muilenburg; Marcia Willing; Guillaume Jondeau; Catherine Boileau; Hariyadarshi Pannu; Rocio Moran; Julie Debacker; Michael J Bamshad; Jay Shendure; Deborah A Nickerson; Suzanne M Leal; C S Raman; Eric C Swindell; Dianna M Milewicz
Journal:  Am J Hum Genet       Date:  2014-12-31       Impact factor: 11.025

3.  Methionine adenosyltransferase II-dependent histone H3K9 methylation at the COX-2 gene locus.

Authors:  Yohei Kera; Yasutake Katoh; Mineto Ohta; Mitsuyo Matsumoto; Teruko Takano-Yamamoto; Kazuhiko Igarashi
Journal:  J Biol Chem       Date:  2013-03-28       Impact factor: 5.157

4.  MAT2B mediates invasion and metastasis by regulating EGFR signaling pathway in hepatocellular carcinoma.

Authors:  Lijun Wu; Ping Chen; Jun Ying; Qi Zhang; Fuchen Liu; Bin Lv; Zhihui Che; Wenli Zhang; Mengmeng Wu; Jun Zhang; Dongqin Yang; Jie Liu
Journal:  Clin Exp Med       Date:  2019-09-06       Impact factor: 3.984

Review 5.  Enzymatic Transition States and Drug Design.

Authors:  Vern L Schramm
Journal:  Chem Rev       Date:  2018-10-18       Impact factor: 60.622

6.  Acetylation of MAT IIα represses tumour cell growth and is decreased in human hepatocellular cancer.

Authors:  Hong-Bin Yang; Ying-Ying Xu; Xiang-Ning Zhao; Shao-Wu Zou; Ye Zhang; Min Zhang; Jin-Tao Li; Feng Ren; Li-Ying Wang; Qun-Ying Lei
Journal:  Nat Commun       Date:  2015-04-30       Impact factor: 14.919

7.  Expression of methionine adenosyltransferase 2A in renal cell carcinomas and potential mechanism for kidney carcinogenesis.

Authors:  Xuliang Wang; Xiaoqiang Guo; Wenshui Yu; Cailing Li; Yaoting Gui; Zhiming Cai
Journal:  BMC Cancer       Date:  2014-03-17       Impact factor: 4.430

8.  CDK12 regulates co-transcriptional splicing and RNA turnover in human cells.

Authors:  Brian Magnuson; Karan Bedi; Ishwarya Venkata Narayanan; Bartlomiej Bartkowiak; Hailey Blinkiewicz; Michelle T Paulsen; Arno Greenleaf; Mats Ljungman
Journal:  iScience       Date:  2022-08-28

9.  Expansion of the RNAStructuromeDB to include secondary structural data spanning the human protein-coding transcriptome.

Authors:  Warren B Rouse; Collin A O'Leary; Nicholas J Booher; Walter N Moss
Journal:  Sci Rep       Date:  2022-08-25       Impact factor: 4.996

Review 10.  RNA methyltransferase METTL16: Targets and function.

Authors:  Emily R Satterwhite; Kyle D Mansfield
Journal:  Wiley Interdiscip Rev RNA       Date:  2021-07-06       Impact factor: 9.349

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.